Caplin Point Laboratories Limited — Important, 01-09-2026: Updates
01-09-2026 | 05:59 pm
01-09-2026 | 05:59 pm
Caplin Point's subsidiary, Caplin One Labs, secured crucial GMP compliance from INVIMA, Colombia. This enables its unit to manufacture sterile & non-sterile oncology drugs like injections, tablets, and capsules. Opens significant market access and growth opportunities in Colombia for these specialized products.
No comments yet. Be the first to comment!
